Assistant Professor of Medicine, Tarek Alhamad, MD, MS, FACP, FASN, Transplant Nephrology, has been awarded a grant from Mallinckrodt Pharmaceuticals. The investigator-initiated project is entitled Efficacy of Acthar in Recurrent Focal Segmental Glomerulosclerosis after Kidney Transplantation. “Recurrence of primary focal segmental glomerulosclerosis (FSGS) after kidney transplantation remains a frequent medical challenge,” says Dr. Alhamad. “Around […]
Tarek Alhamad Receives Mallinckrodt Grant to Look at FSGS
